Phlox Pharmaceuticals Ltd

Phlox was incorporated in 1995, and has set up a state of art dedicated facility for the manufacture of bulk cephalosporin antibiotics. With dedicated buildings for the manufacture of oral and sterile bulk cephalosporin Phlox has been certified with WHO GMP for its good manufacturing practices and accredited with ISO 9002 by DNV Zertifizierung und Umeltguachter GmbH.

Manufacturers of Cephalosporin antibiotics.
Active Pharmaceutical Ingredients(BP/USP/EP/In-house specifications):
Cefuroxime axitle amorphous
Cefuroxime sodium sterile

Cefixime
Cefotaxime sodium sterile

Cefdinir
Cefazolin sodium sterile

Cephradine sterile
Cefepime (Under development)

Cefperome (Under development)

Semifinished Products:
Cefuroxime Axitel DC Grade Cefixime granules for Suspension (pre mixed suspension ready for filling)
Cefuroxime Axitel coated granules for suspension.(bitterless) Cefdinir granules DC grade
Cefuroxime Axitel granules for suspension (pre mixed suspension ready for filling)

Activity:

- Contract Manufacturing
- Manufacturing
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Generics
- FP (finished products)
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Infectious Diseases

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Far East , Asia , Near/Middle East , Central/South America , Europe , North America , Australia/New-Zealand , Central/South America

c. Countries active: HK, China, Malaysia, Iran, Jordan

Corporate data:

Number of Employees: 115

Turnover:

Amount:	Year:	Currency:
10000000	1999	US Dollar

Year founded: 1996